Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simak

Showing results (181-190 of 636) with videos related to

Pageof 64
Sort By:
Plos One|September 24, 2009
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in RussiaYanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Physical Review Letters|October 29, 2013
Hyperfine splitting and room-temperature ferromagnetism of Ni at multimegabar pressureI Sergueev, L Dubrovinsky, M Ekholm, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
Scientific Reports|March 23, 2024
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signalingTommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, et al.
Physical Review Letters|November 12, 2013
Pressure-induced hydrogen bond symmetrization in iron oxyhydroxideWeiming Xu, Eran Greenberg, Gregory Kh Rozenberg, et al.
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Plos One|December 19, 2024
Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
JCI Insight|November 3, 2018
Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticlesSirsendu Jana, Michael Brad Strader, Fantao Meng, et al.
Plos One|February 12, 2016
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
Pageof 64

Showing results (181-190 of 636) with videos related to

Sort By:
Pageof 64
Plos One|September 24, 2009
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in RussiaYanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Physical Review Letters|October 29, 2013
Hyperfine splitting and room-temperature ferromagnetism of Ni at multimegabar pressureI Sergueev, L Dubrovinsky, M Ekholm, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
Scientific Reports|March 23, 2024
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signalingTommaso De Marchi, Chun-Fui Lai, Georgia M Simmons, et al.
Physical Review Letters|November 12, 2013
Pressure-induced hydrogen bond symmetrization in iron oxyhydroxideWeiming Xu, Eran Greenberg, Gregory Kh Rozenberg, et al.
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Plos One|December 19, 2024
Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
JCI Insight|November 3, 2018
Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticlesSirsendu Jana, Michael Brad Strader, Fantao Meng, et al.
Plos One|February 12, 2016
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within MinutesInês G Mollet, Dilipkumar Patel, Fatima S Govani, et al.
Pageof 64